Because dendritic cells (DC), as professional antigen-presenting cells, are crucial to prime and expand antigen-specific CD8+ T-cells, several strategies aim to use or target DCs to induce protective immunity in prophylactic or therapeutic vaccines for infectious diseases or cancer [25]. The gene discussed is CD8A; the disease is cancer.